Characterization of disease-related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners

Human Brain Mapping

Volumn 35, Issue 5, 2014, Pages 1801-1814

  Peng, Shichun ^a   Ma, Yilong ^a   Spetsieris, Phoebe G ^a   Mattis, Paul ^a   Feigin, Andrew ^a   Dhawan, Vijay ^a   Eidelberg, David ^a  

^a Northwell Health   (United States)

Author keywords

Brain imaging; Emission tomography; Parkinson's disease; Principal component analysis; Spatial covariance analysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN TOMOGRAPHY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; GLUCOSE METABOLISM; HUMAN; IMAGE RECONSTRUCTION; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; NERVE CELL NETWORK; NEUROIMAGING; PARKINSON DISEASE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SENSITIVITY AND SPECIFICITY; SSMPCA TOOLBOX; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; ALGORITHM; AREA UNDER THE CURVE; BRAIN; BRAIN MAPPING; COMPUTER PROGRAM; DIAGNOSTIC USE; MIDDLE AGED; PATHOLOGY; REFERENCE VALUE; SCINTISCANNING;

ADULT; AGED; ALGORITHMS; AREA UNDER CURVE; BRAIN; BRAIN MAPPING; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; RADIOPHARMACEUTICALS; REFERENCE VALUES; SOFTWARE;

EID: 84898022661     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22295     Document Type: Article

References (56)

1. Alexander G, Moeller J (1994): Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: A principal component approach to modeling brain function in disease. Human Brain Mapp 2: 1-16.
2. Alexander GE, Chen K, Aschenbrenner M, Merkley TL, Santerre-Lemmon LE, Shamy JL, Skaggs WE, Buonocore MH, Rapp PR, Barnes CA (2008): Age-related regional network of magnetic resonance imaging gray matter in the rhesus macaque. J Neurosci 28: 2710-2718.
3. Asanuma K, Ma Y, Huang C, Carbon M, Edwards C, Raymond D, Bressman S, Moeller JR, Eidelberg D (2005): The metabolic pathology of dopa-responsive dystonia. Ann Neurol 57: 596-600.
4. Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, Kaplitt MG, Feigin A, Eidelberg D (2006): Network modulation in the treatment of Parkinson's disease. Brain 129: 2667-2678.
5. Ashburner J, Friston KJ (1999): Nonlinear spatial normalization using basis functions. Hum Brain Mapp 7: 254-266.
6. Ashburner J, Neelin P, Collins DL, Evans A, Friston K (1997): Incorporating prior knowledge into image registration. Neuroimage 6: 344-352.
7. Asllani I, Habeck C, Scarmeas N, Borogovac A, Brown TR, Stern Y (2008): Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease. J Cereb Blood Flow Metab 28: 725-736.
8. Bergfield KL, Hanson KD, Chen K, Teipel SJ, Hampel H, Rapoport SI, Moeller JR, Alexander GE (2010): Age-related networks of regional covariance in MRI gray matter: Reproducible multivariate patterns in healthy aging. Neuroimage 49: 1750-1759.
9. Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE (2011): Cerebral glucose metabolic features of Parkinson disease and incident dementia: Longitudinal study. J Nucl Med 52: 848-855.
10. Brickman AM, Habeck C, Ramos MA, Scarmeas N, Stern Y (2008): A forward application of age associated gray and white matter networks. Hum Brain Mapp 29: 1139-1146.
11. Caballol N, Marti MJ, Tolosa E (2007): Cognitive dysfunction and dementia in Parkinson disease. Mov Disord 22 (Suppl 17): S358-S366.
12. Chen K, Reiman EM, Alexander GE, Bandy D, Renaut R, Crum WR, Fox NC, Rossor MN (2004): An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer's disease. Neuroimage 22: 134-143.
13. Eckert T, Van Laere K, Tang C, Lewis DE, Edwards C, Santens P, Eidelberg D (2007): Quantification of Parkinson's disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging 34: 496-501.
14. Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, Feigin A, Eidelberg D (2008): Abnormal metabolic networks in atypical parkinsonism. Mov Disord 23: 727-733.
15. Eidelberg D (2009): Metabolic brain networks in neurodegenerative disorders: A functional imaging approach. Trends Neurosci 32: 548-557.
16. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S, et al (1994): The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14: 783-801.
17. Feigin A, Fukuda M, Dhawan V, Przedborski S, Jackson-Lewis V, Mentis MJ, Moeller JR, Eidelberg D (2001): Metabolic correlates of levodopa response in Parkinson's disease. Neurology 57: 2083-2088.
18. Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, Mentis MJ, Moeller JR, Eidelberg D (2002): Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 17: 1265-1270.
19. Feigin A, Kaplitt MG, Tang C, Lin T, Mattis P, Dhawan V, During MJ, Eidelberg D (2007a): Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci USA 104: 19559-19564.
20. Feigin A, Tang C, Ma Y, Mattis P, Zgaljardic D, Guttman M, Paulsen JS, Dhawan V, Eidelberg D (2007b): Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain 130(Pt 11): 2858-2867.
21. Friston K (2007): Statistical Parametric Mapping: The Analysis of Functional Brain Images. London:Academic Press.
22. Fukuda M, Mentis MJ, Ma Y, Dhawan V, Antonini A, Lang AE, Lozano AM, Hammerstad J, Lyons K, Koller WC, et al. (2001): Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: A PET study of resting-state glucose metabolism. Brain 124(Pt 8): 1601-1609.
23. Habeck C, Hilton HJ, Zarahn E, Flynn J, Moeller J, Stern Y (2003): Relation of cognitive reserve and task performance to expression of regional covariance networks in an event-related fMRI study of nonverbal memory. Neuroimage 20: 1723-1733.
24. Habeck C, Foster NL, Perneczky R, Kurz A, Alexopoulos P, Koeppe RA, Drzezga A, Stern Y (2008): Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage 40: 1503-1515.
25. Hirano S, Asanuma K, Ma Y, Tang C, Feigin A, Dhawan V, Carbon M, Eidelberg D (2008): Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci 28: 4201-4209.
26. Hsu JL, Jung TP, Hsu CY, Hsu WC, Chen YK, Duann JR, Wang HC, Makeig S (2007): Regional CBF changes in Parkinson's disease: A correlation with motor dysfunction. Eur J Nucl Med Mol Imaging 34: 1458-1466.
27. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D (2007a): Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 34: 714-723.
28. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D (2007b): Changes in network activity with the progression of Parkinson's disease. Brain 130(Pt 7): 1834-1846.
29. Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D (2008): Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 70(16 Pt 2): 1470-1477.
30. Joliffe IT (2002): Springer Series in Statistics: Principal Components Analysis, 2nd ed. New York:Springer-Verlag.
31. Kerrouche N, Herholz K, Mielke R, Holthoff V, Baron JC (2006): 18FDG PET in vascular dementia: Differentiation from Alzheimer's disease using voxel-based multivariate analysis. J Cereb Blood Flow Metab 26: 1213-1221.
32. Lewitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, et al. (2011): AAV2-GAD gene therapy for advanced Parkinson's disease: A double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10: 309-319.
33. Lozza C, Baron JC, Eidelberg D, Mentis MJ, Carbon M, Marie RM (2004): Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp 22: 236-245.
34. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D (2007): Abnormal metabolic network activity in Parkinson's disease: Test-retest reproducibility. J Cereb Blood Flow Metab 27: 597-605.
35. Ma Y, Peng S, Flores J, Cornfeldt M, Mitrovic B, Eidelberg D, Doudet DJ (2008): Abnormal metabolic brain network in parkinsonian macaques: Modulation by retinal pigment epithelial (RPE) cell implantation. Neurology 71: 154-155 [abstract].
36. Ma Y, Tang C, Moeller JR, Eidelberg D (2009): Abnormal regional brain function in Parkinson's disease: Truth or fiction?Neuroimage 45: 260-266.
37. Ma Y, Huang C, Dyke JP, Pan H, Alsop D, Feigin A, Eidelberg D (2010): Parkinson's disease spatial covariance pattern: Noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab 30: 505-509.
38. Ma Y, Peng S, Spetsieris PG, Sossi V, Eidelberg D, Doudet DJ (2012): Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism. J Cereb Blood Flow Metab 32: 633-642.
39. Mattis PJ, Tang CC, Ma Y, Dhawan V, Eidelberg D (2011): Network correlates of the cognitive response to levodopa in Parkinson disease. Neurology 77: 858-865.
40. Melzer TR, Watts R, Macaskill MR, Pearson JF, Rueger S, Pitcher TL, Livingston L, Graham C, Keenan R, Shankaranarayanan A, et al. (2011): Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain 134(Pt 3): 845-855.
41. Mentis MJ, Mcintosh AR, Perrine K, Dhawan V, Berlin B, Feigin A, Edwards C, Mattis P, Eidelberg D (2002): Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 159: 746-754.
42. Moeller JR, Strother SC (1991): A regional covariance approach to the analysis of functional patterns in positron emission tomographic data. J Cerebral Blood Flow Metab 11: A121-A135.
43. Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Mandel F, Alexander GE, Grady C, Pietrini P, Eidelberg D (1996): The metabolic topography of normal aging. J Cereb Blood Flow Metab 16: 385-398.
44. Moeller JR, Nakamura T, Mentis MJ, Dhawan V, Spetsieres P, Antonini A, Missimer J, Leenders KL, Eidelberg D (1999): Reproducibility of regional metabolic covariance patterns: Comparison of four populations. J Nucl Med 40: 1264-1269.
45. Mure H, Hirano S, Tang CC, Isaias IU, Antonini A, Ma Y, Dhawan V, Eidelberg D (2011): Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects. Neuroimage 54: 1244-1253.
46. Niethammer M, Eidelberg D (2012): Metabolic brain networks in translational neurology: Concepts and applications. Ann Neurol 72: 635-647.
47. Petersson KM, Nichols TE, Poline JB, Holmes AP (1999): Statistical limitations in functional neuroimaging. I. Non-inferential methods and statistical models. Philos Trans R Soc Lond B Biol Sci 354: 1239-1260.
48. Poston KL, Eidelberg D (2009): Network biomarkers for the diagnosis and treatment of movement disorders. Neurobiol Dis 35: 141-147.
49. Scarmeas N, Habeck CG, Zarahn E, Anderson KE, Park A, Hilton J, Pelton GH, Tabert MH, Honig LS, Moeller JR, et al. (2004): Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: Utility in group discrimination and correlations with functional performance. Neuroimage 23: 35-45.
50. Spetsieris PG, Eidelberg D (2011): Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues. Neuroimage 54: 2899-2914.
51. Spetsieris P, Ma Y, Dhawan V, Moeller JR, Eidelberg D (2006): Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging. Proc SPIE: Med Imag 6144: 5M1-5M12.
52. Spetsieris PG, Ma Y, Dhawan V, Eidelberg D (2009): Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage 45: 1241-1252.
53. Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, et al. (2010): Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis. Lancet Neurol 9: 149-58.
54. Trost M, Carbon M, Edwards C, Ma Y, Raymond D, Mentis MJ, Moeller JR, Bressman SB, Eidelberg D (2002): Primary dystonia: Is abnormal functional brain architecture linked to genotype?Ann Neurol 52: 853-856.
55. Trost M, Su S, Su P, Yen RF, Tseng HM, Barnes A, Ma Y, Eidelberg D (2006): Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage 31: 301-307.
56. Zuendorf G, Kerrouche N, Herholz K, Baron JC (2003): Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging. Hum Brain Mapp 18: 13-21.